Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000079
Filing Date
2024-11-18
Accepted
2024-11-18 06:47:55
Documents
50
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 6-K a2024-11x182024agmappendix.htm 6-K 23614
2 EX-99.1 exhibit991-appendix3zxjo.htm EX-99.1 3612
3 EX-99.2 exhibit992-chairsaddress.htm EX-99.2 9653
4 EX-99.3 exhibit993-agm2024presen.htm EX-99.3 46852
5 EX-99.4 exhibit994-resultsofmeet.htm EX-99.4 6580
6 exhibit991-appendix3zxjo001.jpg GRAPHIC 106794
7 exhibit991-appendix3zxjo002.jpg GRAPHIC 93704
8 exhibit992-chairsaddress001.jpg GRAPHIC 260750
9 exhibit992-chairsaddress002.jpg GRAPHIC 307534
10 exhibit993-agm2024presen001.jpg GRAPHIC 64232
11 exhibit993-agm2024presen002.jpg GRAPHIC 158354
12 exhibit993-agm2024presen003.jpg GRAPHIC 83016
13 exhibit993-agm2024presen004.jpg GRAPHIC 108861
14 exhibit993-agm2024presen005.jpg GRAPHIC 131906
15 exhibit993-agm2024presen006.jpg GRAPHIC 103356
16 exhibit993-agm2024presen007.jpg GRAPHIC 106523
17 exhibit993-agm2024presen008.jpg GRAPHIC 149962
18 exhibit993-agm2024presen009.jpg GRAPHIC 118132
19 exhibit993-agm2024presen010.jpg GRAPHIC 120814
20 exhibit993-agm2024presen011.jpg GRAPHIC 90861
21 exhibit993-agm2024presen012.jpg GRAPHIC 66678
22 exhibit993-agm2024presen013.jpg GRAPHIC 68519
23 exhibit993-agm2024presen014.jpg GRAPHIC 94889
24 exhibit993-agm2024presen015.jpg GRAPHIC 146315
25 exhibit993-agm2024presen016.jpg GRAPHIC 106686
26 exhibit993-agm2024presen017.jpg GRAPHIC 99110
27 exhibit993-agm2024presen018.jpg GRAPHIC 133059
28 exhibit993-agm2024presen019.jpg GRAPHIC 130787
29 exhibit993-agm2024presen020.jpg GRAPHIC 95626
30 exhibit993-agm2024presen021.jpg GRAPHIC 87264
31 exhibit993-agm2024presen022.jpg GRAPHIC 138346
32 exhibit993-agm2024presen023.jpg GRAPHIC 69635
33 exhibit993-agm2024presen024.jpg GRAPHIC 52425
34 exhibit993-agm2024presen025.jpg GRAPHIC 125924
35 exhibit993-agm2024presen026.jpg GRAPHIC 108606
36 exhibit993-agm2024presen027.jpg GRAPHIC 131872
37 exhibit993-agm2024presen028.jpg GRAPHIC 109345
38 exhibit993-agm2024presen029.jpg GRAPHIC 73718
39 exhibit993-agm2024presen030.jpg GRAPHIC 64915
40 exhibit993-agm2024presen031.jpg GRAPHIC 151707
41 exhibit993-agm2024presen032.jpg GRAPHIC 151244
42 exhibit993-agm2024presen033.jpg GRAPHIC 165362
43 exhibit993-agm2024presen034.jpg GRAPHIC 121066
44 exhibit993-agm2024presen035.jpg GRAPHIC 153744
45 exhibit993-agm2024presen036.jpg GRAPHIC 136870
46 exhibit993-agm2024presen037.jpg GRAPHIC 120276
47 exhibit993-agm2024presen038.jpg GRAPHIC 38021
48 exhibit994-resultsofmeet001.jpg GRAPHIC 56055
49 exhibit994-resultsofmeet002.jpg GRAPHIC 163471
50 exhibit994-resultsofmeet003.jpg GRAPHIC 125334
  Complete submission text file 0001345099-24-000079.txt   7384207
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 241469730
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)